drugset / Trial / NCT00548925
A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy
Timeline
- Start
- 2007-11
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SOFINICLINE | Small molecule | 6 mg | — |